Compared with the previous four studies, which all tracked the dynamics of IDO1 activity during RT in NSCLC patients (12–15), our study designed different monitoring time points and supported the hypothesis that changing patterns of IDO1 activity during RT were significantly associated with survival outcomes. Here, IDO1 is linked to non-small cell lung carcinoma.